Login / Signup

Olaparib and bevacizumab in front-line maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?

Eduardo PaulinoAndreia Cristina de Melo
Published in: Journal of gynecologic oncology (2021)
Keyphrases
  • phase iii
  • clinical trial
  • open label
  • study protocol
  • phase ii
  • metastatic colorectal cancer
  • double blind
  • randomized controlled trial
  • placebo controlled